EPISODE · Nov 16, 2010 · 10 MIN
The Lancet Neurology: November 16, 2010
from Listen to The Lancet Neurology · host The Lancet
Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
NOW PLAYING
The Lancet Neurology: November 16, 2010
0:00
10:42
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Neurology?
This episode is 10 minutes long.
When was this Listen to The Lancet Neurology episode published?
This episode was published on November 16, 2010.
What is this episode about?
Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
Can I download this Listen to The Lancet Neurology episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!